FDA Inspection
Globopharma, Inc.Globopharma, Inc. – FDA Inspection, Aug 10, 2026
Record Details
This FDA Inspection record concerns Globopharma, Inc., with an inspection on August 10, 2026, issued by the Florida District Office, covering foods & cosmetics.
View Company Profile
ID · f7a8a4eb-94ae-48ec-9fa5-55fa78530d43
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1330352
- FDA center
- Foods & Cosmetics
- Project area
- Food Composition, Standards, Labeling and Econ
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 111.70(b)Specifications - components
- 21 CFR 111.70(e)Specifications - finished dietary supplement
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Globopharma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 21, 2024 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| July 28, 2023 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| July 2, 2019 | Not classified | Florida District Office |
Other documents for Globopharma, Inc.
- FDA Inspection 1241516 - 2024-06-21
- FDA Inspection 1211491 - 2023-07-28
- FDA Inspection 1095015 - 2019-07-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.